The medical course of CLL is very heterogeneous, ranging from a fairly asymptomatic disease that will even regress spontaneously to some progressive sickness that sooner or later results in the patient’s death, so there has normally been extraordinary curiosity in figuring out the prognosis of individual people. Though several prognostic markers